10-Q Filing

BEONE MEDICINES LTD. CIK: 1651308 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0001651308-19-000079`
Period End Date	20190630
Filing Date	20190808
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	beigene2019q210-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 98 Income Statement 74 Cash Flow Statement 95 Stockholders Equity 36 Comprehensive Income 26

Balance Sheet 98 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$918.95M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$438.42M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$712.94M	USD	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	776.26M	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.54M	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$31.59M	USD	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	784.44M	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.57M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$1.07B	USD	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	784.44M	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$618.80M	USD	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	776.26M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$41.06M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$58.11M	USD	Point-in-time
Unbilled receivable	`UnbilledReceivablesCurrent`	-	USD	Point-in-time
Unbilled receivable	`UnbilledReceivablesCurrent`	$8.61M	USD	Point-in-time
Inventories	`InventoryNet`	$49.05M	USD	Point-in-time
Inventories	`InventoryNet`	$16.24M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$81.94M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$96.21M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.76B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.94B	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	-	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$9.16M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$13.23M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$157.06M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$212.67M	USD	Point-in-time
Land use right, net	`LandUseRightNet`	$45.06M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$74.64M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$71.04M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$7.17M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$6.51M	USD	Point-in-time
Goodwill	`Goodwill`	$109.00K	USD	Point-in-time
Goodwill	`Goodwill`	$109.00K	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$29.54M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$31.39M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$60.16M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$53.67M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$394.64M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$305.84M	USD	Point-in-time
Total assets	`Assets`	$2.25B	USD	Point-in-time
Total assets	`Assets`	$2.15B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$148.54M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$113.28M	USD	Point-in-time
Accrued expenses and other payables	`AccountsPayableAndAccruedLiabilitiesCurrent`	$100.41M	USD	Point-in-time
Accrued expenses and other payables	`AccountsPayableAndAccruedLiabilitiesCurrent`	$103.06M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	-	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$18.14M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$2.17M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$5.89M	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$9.17M	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$8.68M	USD	Point-in-time
Current portion of long-term bank loan	`LongTermDebtCurrent`	$8.74M	USD	Point-in-time
Current portion of long-term bank loan	`LongTermDebtCurrent`	$8.73M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$271.68M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$246.45M	USD	Point-in-time
Long-term bank loan	`LongTermDebtNoncurrent`	$40.78M	USD	Point-in-time
Long-term bank loan	`LongTermDebtNoncurrent`	$84.49M	USD	Point-in-time
Shareholder loan	`DueToRelatedPartiesNoncurrent`	$154.32M	USD	Point-in-time
Shareholder loan	`DueToRelatedPartiesNoncurrent`	$148.89M	USD	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	-	USD	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	$9.84M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.66M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.76M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$11.14M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$11.80M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$38.93M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$38.10M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$249.59M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$307.38M	USD	Point-in-time
Total liabilities	`Liabilities`	$579.05M	USD	Point-in-time
Total liabilities	`Liabilities`	$496.04M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 784,439,632 and 776,263,184 shares issued and outstanding as of June 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$78.00K	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 784,439,632 and 776,263,184 shares issued and outstanding as of June 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$77.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.81B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.74B	USD	Point-in-time
Accumulated other comprehensive (loss)/income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-225.00K	USD	Point-in-time
Accumulated other comprehensive (loss)/income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.53M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.26B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.01B	USD	Point-in-time
Total BeiGene, Ltd. shareholders equity	`StockholdersEquity`	$1.55B	USD	Point-in-time
Total BeiGene, Ltd. shareholders equity	`StockholdersEquity`	$1.74B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$17.39M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$14.45M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.75B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.62B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.36B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$684.23M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.57B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.23B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$2.15B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$2.25B	USD	Point-in-time

Income Statement 74 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$52.80M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$85.35M	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$243.35M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$321.18M	USD	2 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$33.10M	USD	2 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$17.84M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$10.81M	USD	2 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$6.26M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$273.95M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$228.76M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$164.25M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$407.11M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$139.89M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$74.08M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$82.25M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$45.16M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$663.00K	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$375.00K	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$187.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$332.00K	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$329.18M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$580.77M	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$359.21M	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$215.85M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-163.05M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-273.86M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-85.83M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-259.59M	USD	2 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$1.89M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$2.89M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$3.44M	USD	2 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$7.36M	USD	2 Qtrs
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$-878.00K	USD	1 Quarter
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$804.00K	USD	2 Qtrs
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$850.00K	USD	2 Qtrs
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$75.00K	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-269.61M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-161.08M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-83.83M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-251.38M	USD	2 Qtrs
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$-3.37M	USD	1 Quarter
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$-6.78M	USD	2 Qtrs
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$2.13M	USD	1 Quarter
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$2.65M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-254.02M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-85.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-157.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-105.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-262.83M	USD	2 Qtrs
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-828.00K	USD	1 Quarter
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-813.00K	USD	2 Qtrs
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-384.00K	USD	1 Quarter
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.35M	USD	2 Qtrs
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-253.21M	USD	2 Qtrs
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-261.48M	USD	2 Qtrs
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-156.89M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-85.57M	USD	1 Quarter
Net loss per share attributable to BeiGene, Ltd., basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	1 Quarter
Net loss per share attributable to BeiGene, Ltd., basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.33	USD	2 Qtrs
Net loss per share attributable to BeiGene, Ltd., basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.38	USD	2 Qtrs
Net loss per share attributable to BeiGene, Ltd., basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.11	USD	1 Quarter
Weighted-average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	698.51M	shares	1 Quarter
Weighted-average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	684.59M	shares	2 Qtrs
Weighted-average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	777.51M	shares	1 Quarter
Weighted-average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	776.14M	shares	2 Qtrs
Net loss per American Depositary Share (ADS), basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-4.24	USD	2 Qtrs
Net loss per American Depositary Share (ADS), basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-4.97	USD	2 Qtrs
Net loss per American Depositary Share (ADS), basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-2.92	USD	1 Quarter
Net loss per American Depositary Share (ADS), basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-1.43	USD	1 Quarter
Weighted-average ADSs outstanding, basic and diluted (shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstanding`	59.70M	shares	2 Qtrs
Weighted-average ADSs outstanding, basic and diluted (shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstanding`	59.81M	shares	1 Quarter
Weighted-average ADSs outstanding, basic and diluted (shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstanding`	52.66M	shares	2 Qtrs
Weighted-average ADSs outstanding, basic and diluted (shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstanding`	53.73M	shares	1 Quarter

Cash Flow Statement 95 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-254.02M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-85.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-157.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-105.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-262.83M	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$7.11M	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$4.58M	USD	2 Qtrs
Share-based compensation expenses	`ShareBasedCompensation`	$58.99M	USD	2 Qtrs
Share-based compensation expenses	`ShareBasedCompensation`	$36.04M	USD	2 Qtrs
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$10.00M	USD	2 Qtrs
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$49.00M	USD	2 Qtrs
Non-cash interest expense	`InterestExpenseOperatingActivities`	$4.12M	USD	2 Qtrs
Non-cash interest expense	`InterestExpenseOperatingActivities`	$3.76M	USD	2 Qtrs
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-1.46M	USD	2 Qtrs
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-8.41M	USD	2 Qtrs
Disposal gain on available-for-sale securities	`MarketableSecuritiesRealizedGainLoss`	$1.81M	USD	2 Qtrs
Disposal gain on available-for-sale securities	`MarketableSecuritiesRealizedGainLoss`	$2.34M	USD	2 Qtrs
Non-cash amortization of bond discount	`AmortizationOfDebtDiscountPremium`	$-3.65M	USD	2 Qtrs
Non-cash amortization of bond discount	`AmortizationOfDebtDiscountPremium`	-	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$3.74M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$17.05M	USD	2 Qtrs
Unbilled receivable	`IncreaseDecreaseInContractWithCustomerAsset`	$-3.60M	USD	2 Qtrs
Unbilled receivable	`IncreaseDecreaseInContractWithCustomerAsset`	$-8.61M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-4.61M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$32.81M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$27.67M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$14.54M	USD	2 Qtrs
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightofUseAsset`	$3.60M	USD	2 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$3.69M	USD	2 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$10.29M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$10.31M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$21.43M	USD	2 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$3.54M	USD	2 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$25.44M	USD	2 Qtrs
Tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-8.01M	USD	2 Qtrs
Tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-3.71M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-27.98M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-3.44M	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$21.00K	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-197.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$383.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-221.64M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-218.08M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.31M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$43.27M	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$1.20B	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$710.79M	USD	2 Qtrs
Proceeds from sale or maturity of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$1.17B	USD	2 Qtrs
Proceeds from sale or maturity of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$869.01M	USD	2 Qtrs
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$49.00M	USD	2 Qtrs
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$10.00M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-360.22M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$364.43M	USD	2 Qtrs
Proceeds from follow-on public offering, net of underwriter discount	`ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount`	-	USD	2 Qtrs
Proceeds from follow-on public offering, net of underwriter discount	`ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount`	$758.00M	USD	2 Qtrs
Payment of follow-on public offering cost	`PaymentsOfStockIssuanceCosts`	$414.00K	USD	2 Qtrs
Payment of follow-on public offering cost	`PaymentsOfStockIssuanceCosts`	-	USD	2 Qtrs
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	$4.00M	USD	2 Qtrs
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	-	USD	2 Qtrs
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	$43.70M	USD	2 Qtrs
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	$42.31M	USD	2 Qtrs
Proceeds from option exercises and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$10.64M	USD	2 Qtrs
Proceeds from option exercises and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$10.58M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$58.35M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$810.48M	USD	2 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-2.73M	USD	2 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.78M	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$230.41M	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$201.96M	USD	2 Qtrs
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$239.60M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$740.71M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$942.68M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$470.01M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$239.60M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$740.71M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$942.68M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$470.01M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$918.95M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$438.42M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$712.94M	USD	Point-in-time
Restricted cash, current	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.54M	USD	Point-in-time
Restricted cash, current	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$31.59M	USD	Point-in-time
Restricted cash, current	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.57M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	-	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$9.16M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$13.23M	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$11.84M	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$7.87M	USD	2 Qtrs
Interest expense paid	`InterestPaidNet`	$667.00K	USD	2 Qtrs
Interest expense paid	`InterestPaidNet`	$2.09M	USD	2 Qtrs
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$8.01M	USD	2 Qtrs
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$35.93M	USD	2 Qtrs
Changes in operating assets and liabilities adjusted through accumulated deficit	`CumulativeEffectOnRetainedEarningsNetOfTax1`	-	USD	2 Qtrs
Changes in operating assets and liabilities adjusted through accumulated deficit	`CumulativeEffectOnRetainedEarningsNetOfTax1`	$-2.29M	USD	2 Qtrs

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.75B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.62B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.36B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$684.23M	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.57B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.23B	USD	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	784.44M	shares	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	776.26M	shares	Point-in-time
Contributions from shareholders	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$4.00M	USD	1 Quarter
Issuance of ordinary shares in connection with follow-on public offering	`StockIssuedDuringPeriodValueNewIssues`	$757.59M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$26.39M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$32.60M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$17.40M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$18.64M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units (RSUs)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.27M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units (RSUs)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.31M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units (RSUs)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.37M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units (RSUs)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.27M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$2.75M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$601.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$4.44M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-6.44M	USD	1 Quarter
Net loss	`ProfitLoss`	$-254.02M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-85.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-157.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-105.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-262.83M	USD	2 Qtrs
Balance at the ending of period (in shares)	`CommonStockSharesOutstanding`	784.44M	shares	Point-in-time
Balance at the ending of period (in shares)	`CommonStockSharesOutstanding`	776.26M	shares	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.75B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.62B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.36B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$684.23M	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.57B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.23B	USD	Point-in-time

Comprehensive Income 26 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-254.02M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-85.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-157.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-105.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-262.83M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-3.58M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$2.03M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-7.34M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$2.31M	USD	2 Qtrs
Unrealized holding gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$901.00K	USD	1 Quarter
Unrealized holding gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.59M	USD	2 Qtrs
Unrealized holding gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$719.00K	USD	1 Quarter
Unrealized holding gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.05M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-92.39M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-154.96M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-259.48M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-256.02M	USD	2 Qtrs
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-523.00K	USD	1 Quarter
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-1.33M	USD	2 Qtrs
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-1.06M	USD	2 Qtrs
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-870.00K	USD	1 Quarter
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-258.15M	USD	2 Qtrs
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-91.87M	USD	1 Quarter
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-154.09M	USD	1 Quarter
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-254.96M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.